Patients with end-stage renal disease (ESRD) are at increased risk of acquired cystic kidney disease (ACKD) and renal tumors, but the molecular basis of such disorders remains elusive. In this study, we performed spatial immunogenomic analyses on 268 specimens from 43 patients with ACKD and associated tumors. The molecular landscape of ESRD-associated tumors is different from that of sporadic renal cell carcinoma. Single-cell and spatial analyses have shown that ACKD is under an inflammatory environment and that the renal cysts in ACKD are derived from proximal tubular cells that have survived the destructive effects of inflammation. Interestingly, we revealed that cysts are formed by clonal expansion and that paracrine activation of the MET tyrosine kinase pathway by the surrounding environment nurtures cysts. Collectively, our results identify the oncogenic mechanisms of ESRD-associated renal tumors and will pave the way for improving the prognosis of patients with ESRD. Significance: We elucidated the molecular basis of renal cancer arising in patients with ESRD and show that the inflammatory environment of ESRD gives rise to field cancerization. See related commentary by Sager et al., p. 426
Supplementary Table 1. Data summary of patients on dialysis. Supplementary Table 2. Significantly mutated genes in tumor in patients on dialysis. Supplementary Table 3. Data summary of patients not on HD. Supplementary Table 4. Genes sepcific to ACD. Supplementary Table 5. Gene list of pure PT cells. Supplementary Table 6. Genes sepcific to the cyst cluster. Supplementary Table 7. Recurrently mutated genes detected in LMD.
Supplementary Figure 6: a, Expression patterns of PT-related gene sets in UMAP plots of the integrated scRNA-seq data of the renal cortex of 5 HD patients with ACD-RCC. Supplementary Figure 7: a, Inferred CNV profiles of cyst cells with macrophages used as references. The yellow and green clusters in each figure represent heterogeneous expression clusters of cells within the same cyst. Supplementary Figure 8: a, Expression levels of HGF (macrophage) and MET (cyst) genes in UMAP plots of the integrated scRNA-seq data.
Patients with end-stage renal disease (ESRD) are at increased risk of acquired cystic kidney disease (ACKD) and renal tumors, but the molecular basis of such disorders remains elusive. In this study, we performed spatial immunogenomic analyses on 268 specimens from 43 patients with ACKD and associated tumors. The molecular landscape of ESRD-associated tumors is different from that of sporadic renal cell carcinoma. Single-cell and spatial analyses have shown that ACKD is under an inflammatory environment and that the renal cysts in ACKD are derived from proximal tubular cells that have survived the destructive effects of inflammation. Interestingly, we revealed that cysts are formed by clonal expansion and that paracrine activation of the MET tyrosine kinase pathway by the surrounding environment nurtures cysts. Collectively, our results identify the oncogenic mechanisms of ESRD-associated renal tumors and will pave the way for improving the prognosis of patients with ESRD.Significance:We elucidated the molecular basis of renal cancer arising in patients with ESRD and show that the inflammatory environment of ESRD gives rise to field cancerization.See related commentary by Sager et al., p. 426
Supplementary Figure 1: a, Frequencies of mutations identified in ACD-RCC (left), ESRD-ccRCC (middle), and sporadicccRCC (right). Supplementary Figure 2: a, UMAP plot of the transcriptomes of tumours from HD patients. Supplementary Figure 3: a, eGFR in the expression-defined cluster groups. The green and pink groups correspond to the groups shown in Figure 3a. Supplementary Figure 4: a, Representative images of each marker via mIHC. Supplementary Figure 5: a, Spatial expression patterns of PT genes and DT genes in the renal cortex of patients not on HD. Scale bar, 2 mm.